The Michael J. Fox Foundation is accepting pre-proposals for three funding programs to support work with significant promise and potential for patient-relevant breakthroughs.
- Translational Pipeline– to validate targets and develop test therapies
- Biomarkers to Support Therapeutic Trials– to inform and transform therapeutic development
- Novel PET Tracer Development– to accelerate early tracer development for high-priority targets
Learn more at michaeljfox.org/funding.
The pre-proposal is due to the Office of Sponsored Research and Programs no later than April 21 at 5 p.m.